Data for "Hesperetin rescues amyloid beta-induced defects in neurite outgrowth under MCI-like cellular conditions".
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Abstract
Figure 1. Addition of aggregated Aβ (25–35) inhibits morphological differentiation in N1E-115 cells. (A, B) N1E-115 cells were treated with (+) aggregated Aβ (25–35) or vehicle control (-) at half-maximal inhibitory concentration (13 µM). Cells were allowed to differentiate morphologically for 0 or 3 days (white dotted lines surround typical morphologically differentiated or undifferentiated cells). Cells with processes were counted as differentiated and statistically depicted in the graph (** p < 0.01; n = 10 fields). (C, D) Following the induction of differentiation, cells were collected at days 0 and 3, lysed, and immunoblotted with antibodies against GAP43, Tau, and an internal control protein (GAPDH). The quantified immunoreactive bands were normalized to internal control proteins (** p < 0.01; n = 3). Figure 2. Addition of soluble Aβ (25–35) does not significantly change morphological differentiation in N1E-115 cells. (A, B) N1E-115 cells were treated with (+) 13 µM soluble Aβ (25–35) or vehicle control (-). Cells were allowed to differentiate morphologically for 0 or 3 days (white dotted lines surround typical morphologically differentiated cells). Cells with processes were counted as differentiated and statistically depicted in the graph. (C, D) Following the induction of differentiation, cells were collected at days 0 and 3, lysed, and immunoblotted with antibodies against GAP43, Tau, and GAPDH. The quantified immunoreactive bands were normalized to internal control proteins. Figure 3. Aggregated Aβ does not significantly affect morphological differentiation in long-term cultured N1E-115 cells. (A, B) N1E-115 cells were allowed to differentiate for 1 week. Then, cells were treated without (-, vehicle control) or with (+) 13 µM aggregated Aβ (25–35). Cells were allowed to differentiate morphologically for an additional 3 days. Cells with processes were counted as differentiated and statistically depicted in the graph. (C, D) Cells were collected, lysed, and immunoblotted with antibodies against GAP43, Tau, and GAPDH. The quantified immunoreactive bands were normalized to internal control proteins. Figure 4. Addition of aggregated Aβ decreases the phosphorylation of MAPK/ERK and levels of the GTP-bound form of Ras. (A, B) N1E-115 cells were allowed to differentiate in the presence (+) or absence (-, vehicle control) of aggregated Aβ for 3 days. Cells were then collected and lysed for immunoblotting using antibodies against phosphorylated MAPK/ERK (pMAPK), MAPK/ERK (MAPK), or GAPDH. The quantified immunoreactive bands were normalized to control total proteins (** p < 0.01; n = 3). (C, D) Cell lysates were used for the pull-down assay to detect active, GTP-bound Ras. Total Ras was also detected in immunoblotting (GTP-bound Ras was normalized to total Ras; * p < 0.05; n = 3). Figure 5. Hesperetin recovers the effects of aggregated Aβ on morphological differentiation. (A, B) N1E-115 cells were treated with aggregated Aβ at half-maximal inhibitory concentration (13 µM) in the presence (+) or absence (-, vehicle control) of 10 µM hesperetin (Hes). Cells were allowed to differentiate morphologically for 0 or 3 days (white dotted lines surround typical morphologically differentiated or undifferentiated cells). Cells with processes were counted as differentiated and statistically depicted in the graph (** p < 0.01; n = 10 fields). (C, D) Following the induction of differentiation, cells were collected at days 0 and 3, lysed, and immunoblotted with antibodies against GAP43, Tau, and GAPDH. The quantified immunoreactive bands were normalized to internal control proteins (** p < 0.01; n = 3). Figure 6. Hesperetin recovers the effects of aggregated Aβ on MAPK phosphorylation and levels of GTP-bound Ras. (A, B) Aggregated Aβ-treated N1E-115 cells were allowed to differentiate in the presence (+) or absence (-, vehicle control) of hesperetin (Hes) for 3 days. Cells were then collected and lysed for immunoblotting using antibodies against phosphorylated MAPK/ERK (pMAPK), MAPK/ERK (MAPK), or GAPDH. The quantified immunoreactive bands were normalized to control total proteins (** p < 0.01; n = 3). (C, D) Cell lysates were used for the pull-down assay to detect active, GTP-bound Ras. Total Ras was also detected in immunoblotting (GTP-bound Ras was normalized to total Ras; * p < 0.05; n = 3).Figure S1. Addition of aggregated Aβ (25–35) inhibits morphological differentiation in N1E-115 cells in a concentration-dependent manner. (A) N1E-115 cells were treated with the indicated concentrations of aggregated Aβ (25–35). Cells were allowed to differentiate morphologically for 3 days. In the upper eight images, typically differentiated or undifferentiated cells are surrounded by dotted red lines. In the lower eight images, cell bodies are surrounded by dotted white lines. Dying cells incorporated trypan blue dye (blue). (B) The percentages of trypan blue dye–positive cells increased in an Aβ concentration-dependent manner (blue in graph). Cells with processes were counted as differentiated and statistically depicted in the graph (red) (** p < 0.01; n = 10 filed). Figure S2. Addition of aggregated Aβ inhibits neurite elongation in primary cortical neurons in short-term culture. (A, B) Primary cortical neurons, which were transfected with the plasmid encoding enhanced GFP to identify cell morphologies, were treated with (+) or without (-, vehicle control) aggregated Aβ (25–35) at 13 µM. Neuron culture continued for 0.5 or 3 days. Typically differentiated or undifferentiated cells are surrounded by dotted white lines. Cells with differentiated phenotypes are statistically depicted in the graph (** p < 0.01; n = 10 field). Figure S3. Hesperetin recovers aggregated Aβ-induced inhibition of neurite elongation in primary cortical neurons in short-term culture. (A, B) Primary cortical neurons, which were transfected with the plasmid encoding enhanced GFP to identify cell morphologies, were treated with 13 µM aggregated Aβ (25–35) in the presence (+) or absence (-, vehicle control) of 10 µM hesperetin (Hes). Neuron culture continued for 0.5 or 3 days. Typically differentiated or undifferentiated cells are surrounded by dotted white lines. Cells with differentiated phenotypes are statistically depicted in the graph (** p < 0.01; n = 10 field). Figure S4. The effect of aggregated Aβ on primary cortical neurons in the long-term culture condition. (A, B) Primary cortical neurons transfected with the plasmid encoding enhanced GFP to identify cell morphologies were cultured for 1 week. Then, neurons were treated with or without 13 µM aggregated Aβ (25–35) for 3 days. Typically differentiated cells are surrounded by dotted white lines. Cells with differentiated phenotypes are statistically depicted in the graph (** p < 0.01; n = 10 field).
Fields of Study & Subjects
Alzheimer's disease research and treatments
Medicinal Plants and Neuroprotection
Neuroinflammation and Neurodegeneration Mechanisms
Publication details
- Journal / source
- Figshare
- Publication date
- 26 March 2026
- Language
- EN
- Document type
- Dataset